Skip to main
HCA

HCA Healthcare (HCA) Stock Forecast & Price Target

HCA Healthcare (HCA) Analyst Ratings

Based on 20 analyst ratings
Buy
Strong Buy 35%
Buy 30%
Hold 30%
Sell 5%
Strong Sell 0%

Bulls say

HCA Healthcare is well positioned in the healthcare industry with its large and diverse network of hospitals and outpatient facilities, and its strong market presence in key areas of the country. Despite facing headwinds from healthcare exchange and payor dynamics, the company's management continues to demonstrate strong execution and growth strategies, reflected in the company's consistently solid financial performance and solid margins. With a focus on sustainability and environmental responsibility, HCA Healthcare also stands out as a socially responsible leader in the industry.

Bears say

HCA Healthcare is facing several challenges, such as a decline in admissions due to atypical weather and respiratory volume disruptions, and a potential decline in patient collections from Silver plan members. Moreover, changes in macro and local-market factors can significantly affect admissions growth, potentially impacting HCA's earnings. Additionally, the company faces significant bad debt expenses and potential investigational risks. However, HCA's strong scale, diversified business mix, and attractive clinical quality metrics may support its growth in the long-term.

HCA Healthcare (HCA) has been analyzed by 20 analysts, with a consensus rating of Buy. 35% of analysts recommend a Strong Buy, 30% recommend Buy, 30% suggest Holding, 5% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of HCA Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About HCA Healthcare (HCA) Forecast

Analysts have given HCA Healthcare (HCA) a Buy based on their latest research and market trends.

According to 20 analysts, HCA Healthcare (HCA) has a Buy consensus rating as of Aug 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $477.10, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $477.10, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

HCA Healthcare (HCA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.